Document:

EMPLOYMENT AGREEMENT

 

This EMPLOYMENT AGREEMENT
(the “Agreement”), dated as of December 16, 2021 and effective as of the Effective Date (as defined below), is by and between
by and between Star Equity Holdings, Inc. (the “Company”) and Richard K. Coleman, Jr. (the “Executive” and together
with the Company the “Parties”).

 

W I T N E S S E T H:

 

WHEREAS, the Company wishes
to employ the Executive and the Executive wishes to be employed by the Company in accordance with the terms and conditions set forth below,
including those set forth in Exhibit A, which Executive agrees and acknowledges are a material part of this Agreement.

 

NOW, THEREFORE, in consideration
of the conditions and mutual covenants contained in this Agreement, the parties agree as follows:

 

1.                 
Title and Job Duties.

 

(a)              
Subject to the terms and conditions set forth in this Agreement, the Company agrees to employ Executive as Chief Operating Officer.
In this capacity, Executive shall have the duties, authorities, and responsibilities as the Company’s Board of Directors (the “Board”)
shall designate from time to time. In performing his duties under this Agreement, Executive shall report to the Executive Chairman of
the Board.

 

(b)              
Executive accepts such employment and agrees, during the Term (as defined below), to devote his full business and professional
time and energy to the Company. Executive agrees to carry out and abide by all lawful directions of the Board and to comply with all standards
of performance, policies, and other rules and regulations heretofore established by Company and or hereafter established by Company.

 

(c)              
Without limiting the generality of the foregoing, Executive shall not, without the written approval of the Board, render services
of a business or commercial nature on his own behalf or on behalf of any other person, firm, or corporation, whether for compensation
or otherwise, during his employment hereunder; provided that the foregoing shall not prevent Executive from (i) serving on the boards
of directors of, or holding any other offices or positions in non-profit organizations and, with the prior written approval of the Board,
other for-profit companies, (ii) participating in charitable, civic, educational, professional, community or industry affairs, and
(iii) managing Executive’s passive personal investments do not interfere with Executive’s responsibility to devote his full
business and professional time and energy to the Company, and so long as such activities in the aggregate, (i)-(iii), do not materially
interfere or conflict with Executive’s duties hereunder or create a potential business or fiduciary conflict.

 

(d)              
Executive agrees that the Company may, at any time and for any reason, remove the Executive from any directorship held with any
subsidiary of the Company, and such removal will be effective immediately upon written notice to the Executive unless stated otherwise
in such notice.

 

     

     

    

 

2.                 
Salary and Additional Compensation.

 

(a)              
Base Salary. During the Term, the Company shall pay to Executive an annual base salary (the “Base Salary”),
less applicable withholdings and deductions, of $300,000 on an annualized basis, in accordance with the Company’s normal payroll
procedures. The Executive's Base Salary may be increased at any time by the Compensation Committee of the Board but shall not be decreased
during the term of this Agreement.

 

(b)              
Target Bonus. Starting with the 2022 fiscal year, Executive will be eligible for an annual cash bonus, earned as of the
end of each fiscal year, contingent on achievement of pre-established performance goals mutually developed by the parties annually and
approved by the Compensation Committee, and Executive’s continued employment with the Company through the last day of the fiscal
year (the “Target Bonus”). The Target Bonus shall be 50% of the Base Salary. The Board will assess Executive’s performance
in good faith at the end of each fiscal year. The Target Bonus, if any, will be paid no later than March 15th of the following year.

 

(c)              
Restricted Shares. Executive shall be eligible to receive an annual equity award in the form of restricted share units (the
“RSUs”). In addition, Executive will receive an initial RSU grant of $100,000 at the Effective Date, which shall vest over
three years (one-third on the first, second, and third anniversaries of the Effective Date). For 2022 and later years, the annual award
of RSUs shall be determined by the Compensation Committee of the Board and subject to the rules of the Company’s equity plan and
the award document.

 

(d)              
Other Benefits. The Executive will be entitled to accrue paid vacation at the rate of the greater of (i) four (4) weeks
per year, or (ii) the vacation allowance as provided under the Company's vacation plan that applies to similarly situated employees, provided
any change in the vacation allowance is approved by the Board upon recommendation of the Compensation Committee. In addition, the Company
will provide the Executive with other benefits of employment offered, from time to time to similarly situated employees, provided such
benefits are approved by the Board upon recommendation of the Compensation Committee. In the event Executive chooses to procure his own
health care coverage, Company will reimburse executive monthly in an amount not to exceed the Company-paid portion of similar coverage
offered to other executives.

 

(e)              
Expenses. In accordance with Company policy, the Company shall reimburse Executive for all reasonable business expenses,
including travel expenses, properly and reasonably incurred and paid by Executive in the performance of his duties under this Agreement
upon his presentment of detailed receipts in the form required by the Company’s policy.

 

3.                 
Term of Employment. The terms set forth in this Agreement will commence on January 1, 2022 (the “Effective
Date”) and shall remain in effect until December 31, 2022 (the “Term”), unless earlier terminated as otherwise provided
in Section 4 below. The Term shall automatically renew for additional one (1) calendar year periods (a “Renewal Date”), unless
the Company or Executive has delivered written notice of non-renewal to the other party at least sixty (60) days prior to the relevant
Renewal Date or the Agreement is earlier terminated as otherwise provided in Section 4 below. Notwithstanding this, the Executive employment
with the Company shall be “at will,” meaning that either Executive or the Company shall be entitled to terminate Executive’s
employment at any time and for any reason, with or without Cause, subject to the obligations in Section 4.

 

     

     

    

 

4.                 
Termination.

 

(a)              
Termination at the Company’s Election.

 

(i)               
For Cause. At the election of the Company, Executive’s employment may be terminated for Cause (as defined below)
immediately upon written notice to Executive. For purposes of this Agreement, “Cause” for termination shall mean: (A) the
willful failure of the Executive to perform the Executive's duties and obligations in any material respect (other than any failure resulting
from Executive's disability), (B) intentional acts of dishonesty or willful misconduct by the Executive with respect to the Company, (C)
arrest or conviction of a felony or violation of any law involving dishonesty, disloyalty, moral turpitude, or fraud, or entry of a plea
of guilty or nolo contendere to such charge, (D) his commission at any time of any act of fraud, embezzlement or willful misappropriation
of material Company property, (E) repeated refusal to perform the reasonable and legal instructions of the Board, (F) willful and material
breach of the Executive’s obligations under any material agreement entered into between the Executive and the Company or any of
its affiliates (including under this Agreement and Exhibit A), or willful and material breach of the Company’s polices or
procedures which causes material damage to the Company, its business or reputation, provided that for subsections (A), (E), and (F), if
the breach reasonably may be cured, Executive has been given at least thirty (30) days after Executive’s receipt of written notice
of such breach from the Company to cure such breach. Such written notice shall state in reasonable detail the particular acts or failures
to act that constitute the grounds on which the proposed termination for Cause is based. Whether or not such breach has been cured will
be determined in the reasonable judgment of the Board and if the Board determines that the breach has not been cured, the Board shall
document in writing for Executive the factual basis for why it has determined the breach has not been cured.

 

(ii)             
Upon Disability, Death or Without Cause. At the election of the Company, Executive’s employment may be terminated:
(A) should Executive become physically or mentally unable to perform his duties for the Company hereunder and such incapacity has continued
for a total of ninety consecutive days or for any one hundred eighty days in a period of three hundred sixty-five consecutive days (a
“Disability”); (B) upon Executive’s death (“Death”); or (C) upon sixty (60) days’ written notice to
Executive for any other reason or for no reason at all.

 

(b)              
Termination at the Executive’s Election.

 

(i)               
For Good Reason. Executive may terminate his employment for Good Reason. For purposes of this Agreement, “Good
Reason” for termination shall mean the occurrence of any of the following events (a “Good Reason Condition”), subject
to having complied with the Good Reason Process (as defined below), without Executive’s consent: (i) any material diminution in
the Executive's authority, duties and responsibilities, (ii) any material reduction of the Executive's Base Salary, aggregate incentive
compensation opportunities or aggregate benefits, unless such changes are applied to all members of the Company’s leadership team
and amount to less than a 10% reduction in total, or (iii) a material breach by the Company of this Agreement. Good Reason Process shall
mean that (i) Executive reasonably determines in good faith that a Good Reason Condition has occurred; (ii) Executive notifies the Company
in writing within thirty days of such determination; (iii) the Company is afforded a period of not less than thirty days following such
notice (the “Cure Period”) to remedy the Good Reason Condition; and (iv) the Good Reason Condition continues to exist at the
end of the Cure Period; and (v) Executive terminates his employment for such Good Reason Condition within sixty (60) days after the end
of the Cure Period. If the Company cures the Good Reason Condition during the Cure Period, Good Reason shall be deemed not to have occurred.

 

     

     

    

 

(ii)             
Voluntary Resignation. Notwithstanding anything contained elsewhere in this Agreement to the contrary, Executive
may terminate his employment hereunder at any time and for any reason whatsoever or for no reason at all in Executive’s sole discretion
by giving sixty (60) days’ written notice pursuant to Section 8 of this Agreement (“Voluntary Resignation”).

 

5.                 
Payments Upon Termination of Employment.

 

(a)              
Termination for Cause, Upon Death or Disability, or Voluntary Resignation. If Executive’s employment is terminated
by the Company for Cause, upon Death or Disability, or is terminated by Executive as a Voluntary Resignation, then the Company shall pay
or provide to Executive (or his estate in case of Death) the following amounts only: (i) his Base Salary accrued up to and including the
date of termination or resignation, paid within thirty (30) days or at such earlier time required by applicable law, (ii) unreimbursed
expenses, paid in accordance with this Agreement and the Company’s written policies, and (iv) any vested payment or accrued benefits
under any equity or Company benefit plan, paid pursuant to the terms of such equity or benefit plan (collectively, the “Accrued
Obligations”).

 

6.                 
Termination Without Cause or Non-Renewal. If the Company terminates Executive’s employment Without Cause, the
Executive terminates his employment for Good Reason, or the Executive’s employment terminates subsequent to Company’s notice
of non-renewal, the Company shall begin to pay to Executive (i) the Accrued Obligations, (ii) a pro-rata portion of any Target Bonus that
would have been payable with respect to the fiscal year of termination based on the Target Bonus metrics used to determine actual performance
at the end of the fiscal year, but pro-rated to reflect the number of full months worked during the fiscal year (the “Pro-Rata Bonus”),
with such Pro-Rata Bonus paid on the later of (A) the time the bonus would normally be settled under Section 2(b) or (B) the first business
day after the forty-fifth (45th) day after the date of termination of employment, (iii) provide for immediate vesting of any
RSUs described in Section 2(c) for which the performance period has not been completed as of the date of termination based on the level
of achievement of the performance goals at the end of the performance period, but pro-rated based on the number of full months worked
during the performance period, which shall be settled on the later of (A) the time the RSUs would normally be settled under Section 2(c)
or (B) the first business day after the forty-fifth (45th) day after the date of termination of employment, and (iv) provide
for immediate vesting of any RSUs described in Section 2(c) which are outstanding as of the date of termination, which shall be settled
on the first business day after the forty-fifth (45th) day after the date of termination of employment; provided that payments
of the consideration in (ii)-(iv) is subject to Executive’s execution and delivery of a customary general release (that is no longer
subject to revocation under applicable law) of the Company, its parents, subsidiaries and affiliates and each of their respective officers,
directors, employees, agents, successors and assigns. The payments under this Section 5(b) shall immediately cease should Executive violate
any of the continuing obligations set forth in this Agreement or in Exhibit A to this Agreement, provided that the Company gives
written notice to Executive of the alleged breach within thirty (30) days of the Company’s knowledge of the alleged breach. The
written notice shall state in reasonable detail the particular acts or failures to act that constitute the grounds on which the proposed
cessation of such payments is based. Notwithstanding the foregoing, if the Company terminates the Executive’s employment without
Cause or the Executive resigns from his employment with Good Reason or Executive’s employment terminates due to Company’s
notice of non-renewal, any of the above within twelve months following a Change of Control (as defined below), then the bonus payment
under (ii) above shall equal the equivalent of Executive’s Target Bonus (not a Pro-Rata Bonus) and, in addition to (iii) and (iv)
above, Executive shall receive (v) twelve months of Base Salary, which shall be payable in a single cash lump sum on the sixtieth day
following Executive’s termination (“Change of Control Payment”). For purposes of this Agreement, “Change in Control”
shall mean each of the following with respect to the Company: (i) a sale of all or substantially all of the Company’s assets; (ii)
a sale of the voting securities of the Company such that any person or group of persons who did not hold voting securities of the Company
prior to the transaction hold more than fifty percent (50%) of the combined voting power of the securities of the Company after the transaction;
or (iii) any merger, consolidation or other transaction of the Company with or into another corporation or other entity, other than a
transaction in which the holders of voting securities of the Company immediately prior to such transaction continue to represent (either
by remaining outstanding or by being converted into voting securities of the surviving entity or any parent thereof), at least fifty percent
(50%) of the combined voting power of the securities of the Company or such surviving entity or parent thereof immediately after such
transaction.

 

     

     

    

 

7.                 
Representation and Warranty. Executive represents and warrants to the Company that he is not subject to any agreement
restricting his ability to enter into this Agreement and fully carry out his duties and responsibilities hereunder. Executive hereby indemnifies
and holds the Company harmless against any losses, claims, expenses (including reasonable attorneys’ fees), damages or liabilities
incurred by the Company as a result of a breach of the foregoing representation and warranty.

 

8.                 
Notice. Any notice or other communication required or permitted to be given to any of the parties hereto shall be
deemed to have been given if personally delivered, or if sent by nationally recognized overnight courier, and addressed as follows:

 

If to Executive, to:

 

the address shown on the records of the Company.

 

If to the Company, to:

 

Star Equity Holdings, Inc.

53 Forest Avenue

Old Greenwich, CT 06870

Attention: Jeffrey E. Eberwein

Telephone: 1-203-489-9501

Email: jeff.eberwein@starequity.com

 

with a copy to:

 

Olshan Frome Wolosky LLP

1325 Avenue of the Americas

New York, New York 10019

Attention:Ken Schlesinger

Email: kschlesinger@olshanlaw.com

 

     

     

    

 

8.                 
Severability. If any provision of this Agreement is declared void or unenforceable by a court of competent jurisdiction,
all other provisions shall nonetheless remain in full force and effect.

 

9.                 
Governing Law; Consent to Jurisdiction. This Agreement shall be governed by, and construed and enforced in accordance with,
the laws of the State of Connecticut without regard to the conflict of laws provisions thereof. Each of the parties hereto hereby irrevocably
submits to the exclusive jurisdiction of any appropriate state or federal court of record in Stamford, CT over any action or proceeding
arising out of or relating to this Agreement and each of the parties hereto hereby irrevocably agrees that all claims in respect of such
action or proceeding shall be heard and determined in such Connecticut state or Federal court. Each of the parties hereto hereby irrevocably
waives, to the fullest extent legally possible, the defense of an inconvenient forum to the maintenance of such action or proceeding.

 

10.             
Code Section 409A Compliance.

 

(a)              
The intent of the parties is that payments and benefits under this Agreement comply with, or be exempt from, Code Section 409A
and the regulations and guidance promulgated thereunder (collectively “Code Section 409A”) and, accordingly, to the maximum
extent permitted, this Agreement shall be interpreted and administered accordingly.

 

(b)              
A termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for
the payment of any amounts or benefits upon or following a termination of employment that are considered “nonqualified deferred
compensation” under Code Section 409A unless such termination is also a “separation from service” within the meaning
of Code Section 409A and, for purposes of any such provision of this Agreement, references to a “termination,” “termination
of employment” or like terms shall mean “separation from service.”

 

(c)              
With regard to any provision herein that provides for reimbursement of costs and expenses or in-kind benefits, except as permitted
by Code Section 409A, (i) the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit,
(ii) the amount of expenses eligible for reimbursement, or in-kind benefits, provided during any taxable year shall not affect the expenses
eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year, provided that the foregoing clause (ii) shall
not be violated without regard to expenses reimbursed under any arrangement covered by Code Section 105(b) solely because such expenses
are subject to a limit related to the period the arrangement is in effect and (iii) such payments shall be made on or before the last
day of Executive’s taxable year following the taxable year in which the expense occurred.

 

     

     

    

 

(d)              
For purposes of Code Section 409A, Executive’s right to receive any installment payments pursuant to this Agreement shall
be treated as a right to receive a series of separate and distinct payments. Whenever a payment under this Agreement specifies a payment
period with reference to a number of days (e.g., “within sixty (60) days following the date of termination”), the actual
date of payment within the specified period shall be within the sole discretion of the Company.

 

(e)              
If Executive is a specified employee within the meaning of Section 409A(a)(2)(B)(i) of the Code and would receive any payment sooner
than 6 months after Executive’s “separation from service” that, absent the application of this Section 11(e), would
be subject to additional tax imposed pursuant to Section 409A of the Code as a result of such status as a specified employee, then such
payment shall instead be payable on the date that is the earliest of (i) 6 months after Executive’s “separation from service,”
or (ii) Executive’s death.

 

11.             
Waiver. The waiver by any of the parties hereto of a breach of any provision of this Agreement shall not be construed as
a waiver of any subsequent breach. The failure of a party to insist upon strict adherence to any provision of this Agreement on one or
more occasions shall not be considered a waiver or deprive that party of the right thereafter to insist upon strict adherence to that
provision or any other provision of this Agreement. Any waiver must be in writing.

 

12.             
Assignment. This Agreement is a personal contract and Executive may not sell, transfer, assign, pledge or hypothecate his
rights, interests, and obligations hereunder. Except as otherwise herein expressly provided, this Agreement shall be binding upon and
shall inure to the benefit of Executive and his personal representatives and shall inure to the benefit of and be binding upon the Company
and its successors and assigns, except that the Company may not assign this Agreement without Executive’s prior written consent,
except to an acquirer of all or substantially all of the assets of the Company.

 

13.             
Injunctive Relief. Without limiting the remedies available to the Company, Executive acknowledges that a breach of
any of the covenants contained in Exhibit A would result in material irreparable injury to the goodwill of the Company for which
there is no adequate remedy at law, that it will not be possible to measure damages for such injuries precisely and that, in the event
of such a breach or threat thereof, the Company shall be entitled, without the requirement to post bond or other security, to obtain a
temporary restraining order and/or preliminary or permanent injunction restraining Executive from engaging in activities prohibited by
this Agreement or such other relief as may be required to specifically enforce any of the covenants in Exhibit A of this Agreement,
in addition to all other remedies available at law or in equity.

 

     

     

    

 

14.             
Counterparts. This Agreement may be executed in multiple counterparts, each of which shall be deemed an original and all
of which together shall be considered one and the same agreement and shall become effective when one or more counterparts have been signed
by each of the parties and delivered to the other party. Facsimile or .pdf signatures shall have the same force and effect as original
signatures.

 

15.             
Cooperation. During and after the Term, the Executive agrees to reasonably cooperate with and at the request of the Company
in the defense or prosecution of any legal matter or claim in which the Company, any of its affiliates, or any of their past or present
employees, agents, officers, directors, attorneys, successors or assigns, may be or become involved and which arises or arose during the
Executive's employment. The Executive will be reimbursed for any reasonable out-of-pocket expenses incurred thereby. Such cooperation
will be without additional compensation if Executive is then employed by Company and for reasonable mutually agreeable compensation if
Executive is not then employed by Company.

 

16.             
Administrative Leave. If (i) the Company notifies Executive that he will be terminated without Cause, (ii) the Executive
provides notice of his resignation or termination of his employment for Good Reason or (iii) Executive or the Company provides notice
of its or the Executive's desire not to renew this Agreement, then the Company may place Executive on administrative leave contemporaneously
with or at any time after delivery of such notice. During such administrative leave, the Company shall continue to provide Executive all
of the compensation described in Section 2(a).

 

17.             
Entire Agreement. This Agreement and Exhibit A embodies all of the representations, warranties and agreements between
the parties hereto relating to Executive’s employment with the Company, supersedes and nullifies all previous agreements between
the Parties about the Company’s employment of Executive. No other representations, warranties, covenants, understandings, or agreements
exist between the parties hereto relating to Executive’s employment. This Agreement may not be amended or modified except by a writing
signed by each of the parties hereto. Exhibit A and Sections 5 through 18 shall survive the expiration or termination of this Agreement.

 

IN WITNESS WHEREOF,
the parties hereto have caused this Agreement to be duly executed and delivered on the date above.

 

     

     

    

 

	 	STAR EQUITY HOLDINGS, INC.
	 	 
	 	 
	 	 
	 	By:	
/s/ Jeffrey E. Eberwein
	 	 	
    Name: 

    Title: 
	Jeffrey E. Eberwein

                           Executive Chairman

	 	 
	Agreed to and Accepted:	 
	 	 
	 	 
	
/s/ Richard K. Coleman, Jr.	 
	RICHARD K. COLEMAN, JR.	 
	 	 

 

     

     

    

 

EXHIBIT A

 

NON-COMPETITION, NON-SOLICITATION, PROPRIETARY INFORMATION

AND INVENTIONS AGREEMENT

 

As a condition of Richard
K. Coleman, Jr. (the “Executive”) becoming employed (or Executive’s employment being continued) by between Star Equity
Holdings, Inc., or any of its current or future subsidiaries, affiliates, successors or assigns (collectively, the “Company”),
and in consideration of Executive’s employment with the Company and Executive’s receipt of the compensation now and hereafter
paid to Executive by the Company, Executive agrees to the following (“Exhibit A”):

 

1.                 
Non-Competition and Non-Solicitation Agreement. The Executive acknowledges that the Company (and each of its affiliates)
has invested substantial time, money and resources in the development and retention of its mobile nuclear imaging systems, inventions,
confidential information (including trade secrets), physician network, customers, accounts and business partners. Executive further acknowledges
that during the course of the Executive’s employment with the Company, the Executive will have access to the Company’s technology,
inventions and confidential information (including trade secrets), and will be introduced to existing and prospective customers, accounts
and business partners of the Company. The Executive acknowledges and agrees that any and all “goodwill” associated with any
existing or prospective customer, account or business partner belongs exclusively to the Company, including, but not limited to, any goodwill
created as a result of direct or indirect contacts or relationships between the Executive and any existing or prospective customers, accounts
or business partners. Additionally, the parties acknowledge and agree that Executive possesses skills that are special, unique or extraordinary
and that the value of the Company depends upon his use of such skills on its behalf. In recognition of this, and in consideration of the
Company’s offer to Executive of employment with the Company, the Executive covenants and agrees that:

 

(a)              
During the Relationship, and for a period of two (2) years after it ends, for any reason, the Executive may not, without the prior
written consent of the Board of Directors of the Company, directly or indirectly, perform the same or similar duties that Executive performed
for the Company for any business competitive with the Business of the Company as long as the duties are of the type conducted, authorized,
offered, or provided by Executive within two years prior to the end of the Relationship. This restriction is limited to the territory
where Executive was working for Company at the time of termination of the Relationship.

 

(b)              
During the Relationship, and for a period of two (2) years thereafter, the Executive will not, directly or indirectly, entice,
solicit or encourage any Company employee to leave the employ of the Company or any independent contractor to sever his, her or its engagement
with the Company, absent prior written consent to do so from the Board of Directors of the Company.

 

     

     

    

 

(c)              
During the Relationship, and for a period of two (2) years thereafter, the Executive may not, directly or indirectly, solicit or
attempt to solicit business from the Company’s customers or actively sought prospective customers with whom Executive had material
contact during the Relationship for the purpose of providing products or services that are competitive with those provided by the Company.
“Material contact” exists between Executive and each customer or potential customer with whom Executive dealt, whose dealings
were coordinated or supervised by Executive, about whom Executive obtained confidential information in the ordinary course of business
as a result of Executive’s association with the Company, or who receives products and services from the Company and for which Executive
received compensation, commissions, or earnings during the two-year period prior to the termination of the Relationship. “Products
or services that are competitive with those provided by the Company” includes anything of commercial value that is the same as or
similar to the products or services of the Company.

 

(d)              
For purposes of this Agreement, “Business of the Company” shall mean For purposes of this Agreement, “Business
of the Company” shall mean the business in which the Company and/or its affiliates is currently engaged or in which the Company
will become engaged while Executive is employed by the Company, including, but not limited to, (i) healthcare, including the design,
manufacture, and distribution of diagnostic medical imaging products and the provision of mobile imaging services, (ii) construction,
including the manufacture of modular housing units for commercial and residential real estate projects,
and (iii) manufacturing of structural wall panel and wood foundation items, including building supply distribution operations for professional
builders.

 

2.                 
Provisions Necessary and Reasonable.

 

(a)              
The Executive agrees that (i) the provisions of Section 3 are necessary and reasonable to protect the Company’s confidential
information, inventions, and goodwill; (ii) the specific temporal, geographic and substantive provisions are reasonable and necessary
to protect the Company’s business interests; and (iii) in the event of any breach of any of the covenants set forth herein, the
Company would suffer substantial irreparable harm and would not have an adequate remedy at law for such breach. In recognition of the
foregoing, the Executive agrees that in the event of a breach or threatened breach of any of these covenants, in addition to such other
remedies as the Company may have at law, without posting any bond or security, the Company shall be entitled to seek and obtain equitable
relief, in the form of specific performance, and/or temporary, preliminary or permanent injunctive relief, or any other equitable remedy
which then may be available. The seeking of such injunction or order shall not affect the Company’s right to seek and obtain damages
or other equitable relief on account of any such actual or threatened breach.

 

(b)              
If any of the covenants contained in Section 1 hereof, or any part thereof, are hereafter construed to be invalid or unenforceable,
the same shall not affect the remainder of the covenant or covenants, which shall be given full effect without regard to the invalid portions.

 

(c)              
If any of the covenants contained in Section 1 hereof, or any part thereof, are held to be unenforceable by a court of competent
jurisdiction because of the temporal or geographic scope of such provision or the area covered thereby, the parties agree that the court
making such determination shall have the power to reduce the duration and/or geographic area of such provision and, in its reduced form,
such provision shall be enforceable.

 

     

     

    

 

3.                 
Permitted Activities.

 

(a)              
The parties acknowledge that after Executive leaves the employment of the Company, he may engage in her or his profession as a
sales professional. The parties agree that the following post-employment activities shall not, by themselves, constitute a violation of
the provisions of Section 1 hereof:

 

(i)                
Executive becoming employed by a physician or medical facility with whom Executive had contact while working for the Company, so
long as the employment with such physician or medical facility does not involve the Executive in the process of providing mobile nuclear
imaging services; and

 

(ii)             
Executive becoming employed by a person or entity engaged in the provision of mobile medical care, provided that the employment
does not involve the Executive providing nuclear imaging services to physicians or patients.

 

4.                 
Proprietary Information Protection of Information.

 

(a)              
Executive agrees, at all times during the term of the Relationship and thereafter, to hold in strictest confidence, and not to
use, except for the benefit of the Company to the extent necessary to perform Executive’s obligations to the Company under the Relationship,
and not to otherwise disclose to any person, firm, corporation or other entity, without written authorization from the Company in each
instance, any Proprietary Information (as defined below) that Executive obtains, accesses or creates during the term of the Relationship,
whether or not during working hours, until such Proprietary Information becomes publicly and widely known and made generally available
through no wrongful act of Executive or of others who were under confidentiality obligations as to the item or items involved or if such
disclosure is required by law. Executive further agrees not to make copies of such Proprietary Information except as authorized by the
Company.

 

(b)              
Proprietary Information. Executive understands that for purposes of this Agreement, “Proprietary Information”
includes both Confidential Information and Company Materials as defined below.

 

(i)                
Confidential Information. Executive understands that “Confidential Information” means information and
physical material not generally known or available outside the Company and information and physical material entrusted to the Company
in confidence by third parties. Confidential Information includes, without limitation: (i) Company Inventions (as defined below); (ii)
technical data, trade secrets, know-how, research, product or service ideas or plans, software codes and designs, developments, inventions,
laboratory notebooks, processes, formulas, techniques, mask works, engineering designs and drawings, hardware configuration information,
lists of, or information relating to, suppliers and customers (including, but not limited to, customers of the Company on whom Executive
called or with whom Executive became acquainted during the Relationship), price lists, pricing methodologies, cost data, market share
data, marketing plans, licenses, contract information, business plans, financial forecasts, historical financial data, budgets or other
business information disclosed to Executive by the Company either directly or indirectly, whether in writing, electronically, orally,
or by observation. Executive agrees not to use or disclose directly or indirectly confidential information which does not constitute a
trade secret, during Executive’s employment and after Executive’s employment ends for any reason. Executive agrees to use
directly or directly use or disclose any trade secret, during Executive’s employment and after Executive’s employment ends
for any reason for as long as such information remains a trade secret.

 

     

     

    

 

(ii)             
Company Materials. Executive understands that for purposes of this Agreement, “Company Materials” means
documents or any other media or tangible items that contain or embody Proprietary Information or any other concerning the business, operations
or plans of the Company, whether such documents have been prepared by Executive or by others. Company Materials include, but are not limited
to, blueprints, drawings, photographs, charts, graphs, notebooks, customer lists, computer disks, tapes or printouts, sound recordings
and other printed, typewritten or handwritten documents, as well as samples, prototypes, models, products and the like.

 

(c)              
Third Party Information. Executive’s agreements in this Section 6 are intended to be for the benefit of the Company
and any third party that has entrusted information or physical material to the Company in confidence.

 

(d)              
Other Rights. This Agreement is intended to supplement, and not to supersede, any rights the Company may have in law or
equity with respect to the protection of trade secrets or confidential or proprietary information.

 

5.                 
Ownership of Inventions.

 

(a)              
Inventions Retained and Licensed. Executive has attached hereto, as Exhibit A, a complete list describing with
particularity all Inventions (as defined below) that, as of the Effective Date, belong solely to Executive or belong to Executive jointly
with others, and that relate in any way to any of the Company’s proposed businesses, products or research and development, and which
are not assigned to the Company hereunder; or, if no such list is attached, Executive represents that there are no such Inventions at
the time of signing this Agreement.

 

(b)              
Use or Incorporation of Inventions. If in the course of the Relationship, Executive uses or incorporates into a product,
process or machine any Invention not covered by Section 5(d) of this Agreement in which Executive has an interest, Executive will promptly
so inform the Company. Whether or not Executive gives such notice, Executive hereby irrevocably grants to the Company a nonexclusive,
fully paid-up, royalty-free, assumable, perpetual, worldwide license, with right to transfer and to sublicense, to practice and exploit
such Invention and to make, have made, copy, modify, make derivative works of, use, sell, import, and otherwise distribute under all applicable
intellectual properties without restriction of any kind.

 

(c)              
Inventions. Executive understands that “Inventions” means discoveries, developments, concepts, designs,
ideas, know how, improvements, inventions, trade secrets and/or original works of authorship, technology, algorithms, computer programs,
techniques, whether or not patentable, copyrightable or otherwise legally protectable. Executive understands this includes, but is not
limited to, any new product, machine, article of manufacture, method, procedure, process, technique, use, equipment, device, apparatus,
system, compound, formulation, composition of matter, design or configuration of any kind, or any improvement thereon. Executive understands
that ‘Company Inventions’ means any and all Inventions that Executive may solely or jointly author, discover, develop, conceive,
or reduce to practice during the period of the Relationship.

 

     

     

    

 

(d)              
Assignment of Company Inventions. Executive agrees that he will promptly make full written disclosure to the Company, will
hold in trust for the sole right and benefit of the Company, and hereby assign to the Company, or its designee, all of Executive’s
right, title and interest throughout the world in and to any and all Company Inventions. Executive further acknowledges that all Company
Inventions that are made by Executive (solely or jointly with others) within the scope of and during the period of the Relationship are
‘works made for hire’ (to the greatest extent permitted by applicable law) and are compensated by Executive’s salary.
Executive hereby waives and irrevocably quitclaims to the Company or its designee any and all claims, of any nature whatsoever, that Executive
now has or may hereafter have for infringement of any and all Company Inventions. Executive understands that the obligation to assign
Company Inventions to the Company shall not apply to any Company Invention which is developed entirely on Executive’s own time without
using any of the Company’s equipment, supplies, facilities, and/or Confidential Information unless such Company Invention (i) relates
in any way to the business or to the current or anticipated research or development of the Company or (ii) results in any way from Executive’s
work at the Company.

 

(e)              
Maintenance of Records. Executive agrees to keep and maintain adequate and current written records of all Company Inventions
made by Executive (solely or jointly with others) during the term of the Relationship. The records may be in the form of notes, sketches,
drawings, flow charts, electronic data or recordings, laboratory notebooks, or any other format. The records will be available to and
remain the sole property of the Company at all times. Executive agrees not to remove such records from the Company’s place of business
except as expressly permitted by Company policy which may, from time to time, be revised at the sole election of the Company for the purpose
of furthering the Company’s business. Executive agrees to deliver all such records (including any copies thereof) to the Company
at the time of termination of the Relationship as provided for in Sections 6 and 7.

 

(f)               
Patent and Copyright Rights. Executive agrees to assist the Company, or its designee, at its expense, in every proper way
to secure the Company’s, or its designee’s, rights in the Company Inventions and any copyrights, patents, trademarks, mask
work rights, moral rights, or other intellectual property rights relating thereto in any and all countries, including the disclosure to
the Company or its designee of all pertinent information and data with respect thereto, the execution of all applications, specifications,
oaths, assignments, recordations, and all other instruments which the Company or its designee shall deem necessary in order to apply for,
obtain, maintain and transfer such rights, or if not transferable, waive such rights, and in order to assign and convey to the Company
or its designee, and any successors, assigns and nominees the sole and exclusive right, title and interest in and to such Company Inventions,
and any copyrights, patents, mask work rights or other intellectual property rights relating thereto. Executive further agrees that Executive’s
obligation to execute or cause to be executed, when it is in Executive’s power to do so, any such instrument or papers shall continue
during and at all times after the end of the Relationship and until the expiration of the last such intellectual property right to expire
in any country of the world. Executive hereby irrevocably designates and appoints the Company and its duly authorized officers and agents
as Executive’s agent and attorney-in-fact, to act for and on Executive’s behalf and stead to execute and file any such applications
and to do all other lawfully permitted acts to further the application for, prosecution, issuance, maintenance or transfer of letters
of patents, copyright, mask work and other registrations related to such Company Inventions. This power of attorney is coupled with an
interest and shall not be affected by Executive’s subsequent incapacity.

 

     

     

    

 

6.                 
Company Property; Returning Company Documents. Executive acknowledges and agrees that Executive has no expectation of privacy
with respect to the Company’s telecommunications, networking or information processing systems (including, without limitation, files,
e-mail messages, and voice messages) and that Executive’s activity and any files or messages on or using any of those systems may
be monitored at any time without notice. Executive further agrees that any property situated on the Company’s premises and owned
by the Company and any computer provided by the Company Executive may use in connection with Executive’s duties for the Company
during the Relationship, including disks and other storage media, filing cabinets or other work areas, is subject to inspection by Company
personnel at any time with or without notice. Executive agrees that, at the time of termination of the Relationship, Executive will deliver
to the Company (and will not keep in Executive’s possession, recreate or deliver to anyone else) any and all devices, records, data,
notes, reports, proposals, lists, correspondence, specifications, drawings, blueprints, sketches, laboratory notebooks, materials, flow
charts, equipment, other documents or property, or reproductions of any of the aforementioned items developed by Executive pursuant to
the Relationship or otherwise belonging to the Company, its successors or assigns.

 

7.                 
Termination Certification. In the event of the termination of the Relationship, Executive agrees to sign and deliver the
‘Termination Certification’ attached hereto as Exhibit B; however, Executive’s failure to sign and deliver
the Termination Certification shall in no way diminish Executive’s continuing obligations under this Agreement.

 

8.                 
Notice to Third Parties. Executive understands and agrees that the Company may, with or without prior notice to Executive
and during or after the term of the Relationship, notify third parties of Executive’s agreements and obligations under this Agreement.

 

9.                 
Non-Disparagement. During the Relationship, and thereafter without limitation of time, Executive agrees not to make any
written or oral statements to any person or entity, including the press or any other media, that impugns, disparages or defames or may
reasonably be expected to impugn, disparage of defame (a) the character, ethics, or integrity of the Company or its current or former
employees, officers, directors, shareholders, partners, customers, or owners, or (b) the Company’s work product, business, image
or reputation.

 

10.             
At-Will Relationship. Executive understands and acknowledges that, except as may be otherwise explicitly provided in a separate
written agreement between the Company and Executive, Executive’s Relationship with the Company is and shall continue to be at-will,
as defined under applicable law, meaning that either Executive or the Company may terminate the Relationship at any time for any reason
or no reason, subject to any payment spursuant to an employment or other written agreement, without further obligation or liability, other
than those provisions of this Agreement that explicitly survive the termination of the Relationship.

 

     

     

    

 

11.             
Representations and Covenants.

 

(a)              
Facilitation of Agreement. Executive agrees to execute promptly, both during and after the end of the Relationship, any
proper oath, and to verify any proper document, required to carry out the terms of this Agreement, upon the Company’s written request
to do so.

 

(b)              
No Conflicts. Executive represents that Executive’s performance of all the terms of this Agreement does not and will
not breach any agreement Executive has entered into, or will enter into, with any third party, including without limitation any agreement
to keep in confidence proprietary information or materials acquired by Executive in confidence or in trust prior to or during the Relationship.
Executive will not disclose to the Company or use any inventions, confidential or non-public proprietary information or material belonging
to any previous client, employer or any other party. Executive will not induce the Company to use any inventions, confidential or non-public
proprietary information, or material belonging to any previous client, employer or any other party. Executive acknowledges and agrees
that Executive has listed on Exhibit A all agreements (e.g., non-competition agreements, non-solicitation of customers agreements,
non-solicitation of employees agreements, confidentiality agreements, inventions agreements, etc.), if any, with a current or former client,
employer, or any other person or entity, that may restrict Executive’s ability to accept employment with the Company or Executive’s
ability to recruit or engage customers or service providers on behalf of the Company, or otherwise relate to or restrict Executive’s
ability to perform Executive’s duties for the Company or any obligation Executive may have to the Company. Executive agrees not
to enter into any written or oral agreement that conflicts with the provisions of this Agreement.

 

(c)              
Voluntary Execution. Executive certifies and acknowledges that Executive has carefully read all of the provisions of this
Agreement, that Executive understands and has voluntarily accepted such provisions, and that Executive will fully and faithfully comply
with such provisions.

 

12.             
General Provisions.

 

(a)              
Governing Law/Forum. The validity, interpretation, construction and performance of this Agreement shall be governed by the
laws of the State of Connecticut, without giving effect to the principles of conflict of laws. Both parties agree that the exclusive venue
for any action, demand, claim or counterclaim relating to the terms and provisions of this Agreement shall be in the state or federal
courts located in the State of Connecticut, Fairfield County and that such courts shall have personal jurisdiction over both parties to
this Agreement.

 

(b)              
Entire Agreement. This Agreement and this Exhibit A sets forth the entire agreement and understanding between the Company
and Executive relating to its subject matter and merges all prior discussions between us. No amendment to this Agreement will be effective
unless in writing signed by both parties to this Agreement. The Company shall not be deemed hereby to have waived any rights or remedies
it may have in law or equity, nor to have given any authorizations or waived any of its rights under this Agreement, unless, and only
to the extent, it does so by a specific writing signed by a duly authorized officer of the Company, it being understood that, even if
Executive is an officer of the Company, Executive will not have authority to give any such authorizations or waivers for the Company under
this Agreement without specific approval by the Board of Directors. Any subsequent change or changes in Executive’s duties, obligations,
rights or compensation will not affect the validity or scope of this Agreement.

 

     

     

    

 

(c)              
Severability. If one or more of the provisions in this Agreement are deemed void or unenforceable to any extent in any context,
such provisions shall nevertheless be enforced to the fullest extent allowed by law in that and other contexts, and the validity and force
of the remainder of this Agreement shall not be affected.

 

(d)              
Successors and Assigns. This Agreement will be binding upon Executive’s heirs, executors, administrators and other
legal representatives, and Executive’s successors and assigns, and will be for the benefit of the Company, its successors, and its
assigns.

 

(e)              
Remedies. Executive acknowledges and agrees that violation of this Agreement by Executive may cause the Company irreparable
harm, and therefore agrees that the Company will be entitled to seek extraordinary relief in court, including, but not limited to, temporary
restraining orders, preliminary injunctions and permanent injunctions without the necessity of posting a bond or other security in addition
to and without prejudice to any other rights or remedies that the Company may have for a breach of this Agreement.

 

IN WITNESS WHEREOF,
the Parties hereto have executed this Non-Competition, Non-Solicitation, Proprietary Information and Inventions Agreement.

 

	 	STAR EQUITY HOLDINGS, INC.
	 	 
	 	 
	 	By:	
    /s/ Jeffrey E. Eberwein

	 	 	
    Name: Jeffrey E. Eberwein

    Title: Executive Chairman

	 	 
	Agreed to and Accepted:	 
	 	 
	 	 
	
    /s/ Richard K. Coleman, Jr.
	 
	RICHARD K. COLEMAN, JR.	 
	 	 

 

     

     

    

 

ATTACHMENT 1 TO CONFIDENTIALTY AGREEMENT

 

LIST OF PRIOR INVENTIONS

AND ORIGINAL WORKS OF AUTHORSHIP

EXCLUDED UNDER SECTION 5(a)

 

	
    Title
	
    Date
	
    Identifying
Number

or Brief Description

	 	 	 
	 	 	 
	 	 	 

____ No inventions, improvements, or original works of authorship

 

LIST OF AGREEMENTS THAT MAY RESTRICT MY ACTIVITIES

PURSUANT TO SECTION 11(b)

 

	
    Counterparty
	
    Date
	
    Brief Description
of Agreement and Applicable Restrictions

	 	 	 
	 	 	 
	 	 	 

____ No such agreements

 

____ Additional sheets attached

 

	Signature of Executive:	
	 
	 	 	 
	Print Name of Executive:	
	 
	 	 	 
	Date:	
	 
	 	 	 	 

 

     

     

    

 

EXHIBIT B

 

TERMINATION CERTIFICATION

 

This is to certify that I
do not have in my possession, nor have I failed to return, any devices, records, data, notes, reports, proposals, lists, correspondence,
specifications, drawings, blueprints, sketches, laboratory notebooks, flow charts, materials, equipment, other documents or property,
or copies or reproductions of any aforementioned items belonging to Star Equity Holdings, Inc., or their subsidiaries, affiliates, successors
or assigns (collectively, the “Company”).

 

I further certify that I have
complied with all the terms of the Company’s Proprietary Information and Invention Assignment Agreement (the “Agreement”)
signed by me, including the reporting of any Inventions (as defined therein), conceived or made by me (solely or jointly with others)
covered by that Agreement.

 

I further agree that, in compliance
with the Proprietary Information and Invention Assignment Agreement, I will preserve as confidential all trade secrets, confidential knowledge,
data or other confidential information relating to products, technology, algorithms, computer programs, techniques, technology, know-how,
designs, formulas, developmental or experimental work, computer programs, data bases, other original works of authorship, customer lists,
business plans, financial information or other Proprietary Information, including Confidential Information as defined in Section 4(b)(i)
of the Agreement and Company Materials as defined in Section 4(b)(ii) of the Agreement.

 

I further agree that from
the date of this Certification, I shall not either directly or indirectly solicit, induce, recruit or encourage any of the Company’s
employees or consultants to terminate their relationship with the Company, or attempt to solicit, induce, recruit, encourage or take away
employees or consultants of the Company, either for myself or for any other person or entity if by so doing I would use, disclose or cause
to be disclose Company Confidential Information. Further, I shall not at any time use any Proprietary Information as defined in Section
4(b) of the Agreement to negatively influence any of the Company’s clients or customers from purchasing Company products or services
or to solicit or influence or attempt to influence any client, customer or other person either directly or indirectly, to direct any purchase
of products and/or services to any person, firm, corporation, institution or other entity in competition with the business of the Company.

 

	Date: ________________	 
	 	 
	 	

	 	(Employee’s Signature)
	 	 
	 	

	 	(Print Employee’s Name)Exhibit 4.4

 

WARRANT
AGREEMENT

 

THIS
WARRANT AGREEMENT (“Agreement”) is made as of December__, 2021 between Technology & Telecommunication Acquisition
Corporation, a Cayman Islands exempted company, with offices at C3-2-23A, Jalan 1/152, Taman OUG Parklane, Off Jalan Kelang Lama,
58200 Kuala Lumpur, Malaysia (“Company”), and Continental Stock Transfer & Trust Company, a limited purpose trust
company, with offices at 1 State Street, 30th Floor, New York, New York 10004, as warrant agent (the “Warrant Agent”,
also referred to herein as the “Transfer Agent”).

 

WHEREAS,
the Company is engaged in a public offering (“Public Offering”) of up to 11,500,000 units (including up to 1,500,000
units subject to the Over-allotment Option (as defined below)) (“Public Units”), each Public Unit comprised of one
Class A ordinary share of the Company, par value $0.0001 per share (“Class A ordinary share”), and one-half of one redeemable
warrant, where each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject
to adjustment as described herein, and, in connection therewith, will issue and deliver up to 5,750,000 warrants (including up to 750,000
warrants subject to the Over-allotment Option) (the “Public Warrants”) to the public investors in connection with
the Public Offering; and

 

WHEREAS,
the Company has filed with the Securities and Exchange Commission (the “SEC”) a Registration Statement on Form S-1,
File No. 333-______________ (“Registration Statement”), and a prospectus (the “Prospectus”) for
the registration, under the Securities Act of 1933, as amended (“Act”), of the Public Units, the Public Warrants and
the Class A ordinary shares included in the Public Units; and

 

WHEREAS,
the Company has received binding commitments from Technology & Telecommunication LLC (the “Sponsor”) to purchase
up to an aggregate of 532,500 units (including up to 52,500 units subject to the Over-allotment Option) (“Private Units”)
which will include up to an aggregate of 266,250 warrants (including up to 26,250 warrants subject to the Over-allotment Option) (the
“Private Warrants”) bearing the legend set forth in Exhibit B hereto, in a private placement transaction to occur
simultaneously with the consummation of the Public Offering; and

 

WHEREAS,
the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with
the issuance, registration, transfer, exchange, redemption, and exercise of the Warrants; and

 

WHEREAS,
the Company desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised,
and the respective rights, limitation of rights, and immunities of the Company, the Warrant Agent, and the holders of the Warrants; and

 

WHEREAS,
all acts and things have been done and performed which are necessary to make the Warrants, when executed on behalf of the Company and
countersigned by or on behalf of the Warrant Agent, as provided herein, the valid, binding, and legal obligations of the Company, and
to authorize the execution and delivery of this Agreement.

 

NOW,
THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows:

 

1.
Appointment of Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company for the Warrants,
and the Warrant Agent hereby accepts such appointment and agrees to perform the same in accordance with the terms and conditions set
forth in this Agreement.

 

2.
Warrants.

 

2.1.
Form of Warrant. Each Warrant shall be issued in registered form only, shall be in substantially the form of Exhibit A hereto,
the provisions of which are incorporated herein and shall be signed by, or bear the facsimile signature of, the Chairman of the Board
of Directors or Chief Executive Officer and the Chief Financial Officer, Treasurer, Secretary or Assistant Secretary of the Company and
shall bear a facsimile of the Company’s seal. In the event the person whose facsimile signature has been placed upon any Warrant
shall have ceased to serve in the capacity in which such person signed the Warrant before such Warrant is issued, it may be issued with
the same effect as if he or she had not ceased to be such at the date of issuance.

 

    	 

     

    

 

2.2.
Uncertificated Warrants. Notwithstanding anything herein to the contrary, any Warrant, or portion thereof, may be issued as part
of, and be represented by, a Unit, and any Warrant may be issued in uncertificated or book-entry form through the Warrant Agent and/or
the facilities of The Depository Trust Company or other book-entry depositary system, in each case as determined by the Board of Directors
of the Company or by an authorized committee thereof. Any Warrant so issued shall have the same terms, force and effect as a certificated
Warrant that has been duly countersigned by the Warrant Agent in accordance with the terms of this Agreement.

 

2.3.
Effect of Countersignature. Except with respect to uncertificated Warrants as described above, unless and until countersigned
by the Warrant Agent pursuant to this Agreement, a Warrant shall be invalid and of no effect and may not be exercised by the holder thereof.

 

2.4.
Registration.

 

2.4.1.
Warrant Register. The Warrant Agent shall maintain books (“Warrant Register”) for the registration of original
issuance and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue and
register the Warrants in the names of the respective holders thereof in such denominations and otherwise in accordance with instructions
delivered to the Warrant Agent by the Company.

 

2.4.2.
Registered Holder. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent may
deem and treat the person in whose name such Warrant is then registered in the Warrant Register (“registered holder”)
as the absolute owner of such Warrant and of each Warrant represented thereby (notwithstanding any notation of ownership or other writing
on the Warrant certificate made by anyone other than the Company or the Warrant Agent), for the purpose of any exercise thereof, and
for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary.

 

2.5.
Detachability of Warrants. The securities comprising the Public Units will not be separately transferable until the 90th day following
the date of the Prospectus or, if such 90th day is not on a day, other than Saturday, Sunday or federal holiday, on which banks in New
York City are generally open for normal business (a “Business Day”), then on the immediately succeeding Business Day
following such date, or earlier with the consent of EF Hutton, division of Benchmark Investments, LLC (the “Representative”),
but in no event will the Representative allow separate trading of the securities comprising the Public Units until (i) the Company has
filed a Current Report on Form 8-K which includes an audited balance sheet reflecting the receipt by the Company of the gross proceeds
of the Public Offering including the proceeds received by the Company from the exercise of the underwriters’ over-allotment option
in the Public Offering (the “Over-allotment Option”), if the Over-allotment Option is exercised prior to the filing
of the Form 8-K, and (ii) the Company has issued a press release announcing when such separate trading shall begin (the “Detachment
Date”); provided that no fractional Warrants will be issued upon separation of the Units and only whole Warrants will trade.

 

2.6.
Private Warrant and Working Capital Warrant Attributes. The Private Warrants and Working Capital Warrants will be issued in the
same form as the Public Warrants.

 

2.7
Post IPO Warrants. The Post IPO Warrants, when and if issued, shall have the same terms and be in the same form as the Public
Warrants except as may be agreed upon by the Company.

 

3.
Terms and Exercise of Warrants

 

3.1.
Warrant Price. Each whole Warrant shall, when countersigned by the Warrant Agent (except with respect to uncertificated Warrants),
entitle the registered holder thereof, subject to the provisions of such Warrant and of this Agreement, to purchase from the Company
the number of Class A ordinary shares stated therein, at the price of $11.50 per share, subject to the adjustments provided in Section
4 hereof and in the last sentence of this Section 3.1. The term “Warrant Price” as used in this Agreement refers to the price
per share at which the Class A ordinary shares may be purchased at the time a Warrant is exercised. The Company in its sole discretion
may lower the Warrant Price at any time prior to the Expiration Date (as defined below) for a period of not less than twenty (20) Business
Days; provided, that the Company shall provide at least twenty (20) days’ prior written notice of such reduction to registered
holders of the Warrants and, provided further that any such reduction shall be applied consistently to all of the Warrants.

 

    	2

     

    

 

3.2.
Duration of Warrants. A Warrant may be exercised only during the period commencing on the later of the date by the Company
of a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination
with one or more businesses or entities (“Business Combination”) (as described more fully in the Registration Statement)
or 12 months from the closing of the Public Offering, and terminating at 5:00 p.m., New York City time on the earlier to occur of (i)
five years from the consummation of a Business Combination, (ii) the Redemption Date as provided in Section 6.2 of this Agreement and
(iii) the liquidation of the Company (“Expiration Date”). The period of time from the date the Warrants will first
become exercisable until the expiration of the Warrants shall hereafter be referred to as the “Exercise Period.” Except with
respect to the right to receive the Redemption Price (as set forth in Section 6 hereunder), as applicable, each Warrant not exercised
on or before the Expiration Date shall become void, and all rights thereunder and all rights in respect thereof under this Agreement
shall cease at 5:00 p.m., New York City time, on the Expiration Date. The Company in its sole discretion may extend the duration of the
Warrants by delaying the Expiration Date; provided, however, that the Company will provide at least twenty (20) days’ prior written
notice of any such extension to registered holders and, provided further that any such extension shall be applied consistently to all
of the Warrants.

 

3.3.
Exercise of Warrants.

 

3.3.1.
Payment. Subject to the provisions of the Warrant and this Agreement, a Warrant, when countersigned by the Warrant Agent, may
be exercised by the registered holder thereof by surrendering it, at the office of the Warrant Agent, or at the office of its successor
as Warrant Agent, in the Borough of Manhattan, City and State of New York, with the subscription form, as set forth in the Warrant, duly
executed, and by paying in full the Warrant Price for each full share of Class A ordinary shares as to which the Warrant is exercised
and any and all applicable taxes due in connection with the exercise of the Warrant, the exchange of the Warrant for the Class A ordinary
shares and the issuance of such Class A ordinary shares, as follows:

 

(a)
in lawful money of the United States, by good certified check or wire payable to the Warrant Agent; or

 

(b)
in the event of redemption pursuant to Section 6 hereof in which the Company’s management has elected to force all holders of Warrants
to exercise such Warrants on a “cashless basis,” by surrendering the Warrants for that number of Class A ordinary shares
equal to the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the Warrants, multiplied
by the difference between the Warrant Price and the “Fair Market Value” (defined below) by (y) the Fair Market Value. Solely
for purposes of this Section 3.3.1(b), the “Fair Market Value” shall mean the average reported last sale price of the Class
A ordinary shares for the five (5) trading days ending on the third trading day prior to the date on which the notice of redemption is
sent to holders of the Warrants pursuant to Section 6 hereof; or

 

(c)
in the event the registration statement required by Section 7.4 hereof is not effective and current within sixty (60) Business Days after
the closing of a Business Combination, by surrendering such Warrants for that number of Class A ordinary shares equal to the quotient
obtained by dividing (x) the product of the number of Class A ordinary shares underlying the Warrants, multiplied by the difference between
the exercise price of the Warrants and the “Fair Market Value” by (y) the Fair Market Value; provided, however, that no cashless
exercise shall be permitted unless the Fair Market Value is equal to or higher than the exercise price. Solely for purposes of this Section
3.3.1(c), the “Fair Market Value” shall mean the average reported last sale price of the Class A ordinary shares for the
five (5) trading days ending on the trading day prior to the date of exercise.

 

    	3

     

    

 

3.3.2.
Issuance of Class A Ordinary Shares. As soon as practicable after the exercise of any Warrant and the clearance of the funds in
payment of the Warrant Price (if any), the Company shall issue to the registered holder of such Warrant a certificate or certificates,
or book entry position, for the number of Class A ordinary shares to which he, she or it is entitled, registered in such name or names
as may be directed by him, her or it, and if such Warrant shall not have been exercised in full, a new countersigned Warrant, or book
entry position, for the number of shares as to which such Warrant shall not have been exercised. Notwithstanding the foregoing, in no
event will the Company be required to net cash settle the Warrant exercise. No Warrant shall be exercisable for cash and the Company
shall not be obligated to issue Class A ordinary shares upon exercise of a Warrant unless the Class A ordinary shares issuable upon such
Warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered
holder of the Warrants. In the event that the condition in the immediately preceding sentence is not satisfied with respect to a Warrant,
the holder of such Warrant shall not be entitled to exercise such Warrant for cash and such Warrant may have no value and expire worthless,
in which case the purchaser of a Unit containing such Public Warrants shall have paid the full purchase price for the Unit solely for
the Class A ordinary shares underlying such Unit. Warrants may not be exercised by, or securities issued to, any registered holder in
any state in which such exercise would be unlawful.

 

3.3.3.
Valid Issuance. All Class A ordinary shares issued upon the proper exercise of a Warrant in conformity with this Agreement shall
be validly issued, fully paid and nonassessable.

 

3.3.4.
Date of Issuance. Each person in whose name any book entry position or certificate for Class A ordinary shares is issued shall
for all purposes be deemed to have become the holder of record of such shares on the date on which the Warrant, or book entry position
representing such Warrant, was surrendered and payment of the Warrant Price was made, irrespective of the date of delivery of such certificate,
except that, if the date of such surrender and payment is a date when the share transfer books of the Company or book entry system of
the Warrant Agent are closed, such person shall be deemed to have become the holder of such shares at the close of business on the next
succeeding date on which the share transfer books or book entry system are open.

 

3.3.5
Maximum Percentage. A holder of a Warrant may notify the Company in writing in the event it elects to be subject to the provisions
contained in this subsection 3.3.5; however, no holder of a Warrant shall be subject to this subsection 3.3.5 unless he, she or it makes
such election. If the election is made by a holder, the Warrant Agent shall not affect the exercise of the holder’s Warrant, and
such holder shall not have the right to exercise such Warrant, to the extent that after giving effect to such exercise, such person (together
with such person’s affiliates), to the Warrant Agent’s actual knowledge, would beneficially own in excess of 9.8% (the “Maximum
Percentage”) of the Class A ordinary shares outstanding immediately after giving effect to such exercise. For purposes of the
foregoing sentence, the aggregate number of Class A ordinary shares beneficially owned by such person and its affiliates shall include
the number of Class A ordinary shares issuable upon exercise of the Warrant with respect to which the determination of such sentence
is being made, but shall exclude Class A ordinary shares that would be issuable upon (x) exercise of the remaining, unexercised portion
of the Warrant beneficially owned by such person and its affiliates and (y) exercise or conversion of the unexercised or unconverted
portion of any other securities of the Company beneficially owned by such person and its affiliates (including, without limitation, any
convertible notes or convertible preferred stock or warrants) subject to a limitation on conversion or exercise analogous to the limitation
contained herein. Except as set forth in the preceding sentence, for purposes of this paragraph, beneficial ownership shall be calculated
in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). For purposes
of the Warrant, in determining the number of outstanding Class A ordinary shares, the holder may rely on the number of outstanding Class
A ordinary shares as reflected in (1) the Company’s most recent annual report on Form 10-K, quarterly report on Form 10-Q, current
report on Form 8-K or other public filing with the SEC as the case may be, (2) a more recent public announcement by the Company or (3)
any other notice by the Company or the Transfer Agent setting forth the number of Class A ordinary shares outstanding. For any reason
at any time, upon the written request of the holder of the Warrant, the Company shall, within two (2) Business Days, confirm orally and
in writing to such holder the number of Class A ordinary shares then outstanding. In any case, the number of outstanding Class A ordinary
shares shall be determined after giving effect to the conversion or exercise of equity securities of the Company by the holder and its
affiliates since the date as of which such number of outstanding Class A ordinary shares was reported. By written notice to the Company,
the holder of a Warrant may from time to time increase or decrease the Maximum Percentage applicable to such holder to any other percentage
specified in such notice; provided, however, that any such increase shall not be effective until the sixty-first (61st) day after such
notice is delivered to the Company.

 

4.
Adjustments.

 

4.1.
Stock Dividends; Split Ups. If after the date hereof, and subject to the provisions of Section 4.6 below, the number of outstanding
Class A ordinary shares is increased by a stock dividend payable in Class A ordinary shares, or by a split up of Class A ordinary shares,
or other similar event, then, on the effective date of such stock dividend, split up or similar event, the number of Class A ordinary
shares issuable on exercise of each Warrant shall be increased in proportion to such increase in outstanding Class A ordinary shares.

 

    	4

     

    

 

4.2.
Aggregation of Shares. If after the date hereof, the number of outstanding Class A ordinary shares is decreased by a consolidation,
combination, reverse stock split or reclassification of Class A ordinary shares or other similar event, then, on the effective date of
such consolidation, combination, reverse stock split, reclassification or similar event, the number of Class A ordinary shares issuable
on exercise of each Warrant shall be decreased in proportion to such decrease in outstanding Class A ordinary shares.

 

4.3.
Extraordinary Dividends. If the Company, at any time while the Warrants are outstanding and unexpired, shall pay a dividend or
make a distribution in cash, securities or other assets to the holders of the Class A ordinary shares or other shares of the Company’s
capital stock into which the Warrants are convertible (an “Extraordinary Dividend”), then the Warrant Price shall
be decreased, effective immediately after the effective date of such Extraordinary Dividend, by the amount of cash and the fair market
value (as determined by the Company’s Board of Directors, in good faith) of any securities or other assets paid in respect of such
Extraordinary Dividend divided by all outstanding shares of the Company at such time (whether or not any shareholders waived their right
to receive such dividend); provided, however, that none of the following shall be deemed an Extraordinary Dividend for purposes of this
provision: (a) any adjustment described in subsection 4.1 above, (b) any cash dividends or cash distributions which, when combined on
a per share basis with all other cash dividends and cash distributions paid on the Class A ordinary shares during the 365-day period
ending on the date of declaration of such dividend or distribution does not exceed $0.50 per share (taking into account all of the outstanding
shares of the Company at such time (whether or not any shareholders waived their right to receive such dividend) and as adjusted to appropriately
reflect any of the events referred to in other subsections of this Section 4 and excluding cash dividends or cash distributions that
resulted in an adjustment to the Warrant Price or to the number of Class A ordinary shares issuable on exercise of each Warrant) but
only with respect to the amount of the aggregate cash dividends or cash distributions equal to or less than $0.50, (c) any payment to
satisfy the conversion rights of the holders of the Class A ordinary shares in connection with a proposed initial Business Combination
or certain amendments to the Company’s Articles of Formation (as described in the Registration Statement) or (d) any payment in
connection with the Company’s liquidation and the distribution of its assets upon its failure to consummate a Business Combination.
Solely for purposes of illustration, if the Company, at a time while the Warrants are outstanding and unexpired, pays a cash dividend
of $0.35 and previously paid an aggregate of $0.40 of cash dividends and cash distributions on the Class A ordinary shares during the
365-day period ending on the date of declaration of such $0.35 dividend, then the Warrant Price will be decreased, effectively immediately
after the effective date of such $0.35 dividend, by $0.25 (the absolute value of the difference between $0.75 (the aggregate amount of
all cash dividends and cash distributions paid or made in such 365-day period, including such $0.35 dividend) and $0.50 (the greater
of (x) $0.50 and (y) the aggregate amount of all cash dividends and cash distributions paid or made in such 365-day period prior to such
$0.35 dividend)). Furthermore, solely for the purposes of illustration, if following the closing of the Company’s
initial Business Combination, there were total shares outstanding of 100,000,000 and the Company paid a $1.00 dividend to 17,500,000
of such shares (with the remaining 82,500,000 shares waiving their right to receive such dividend), then no adjustment to the Warrant
Price would occur as a $17.5 million dividend payment divided by 100,000,000 shares equals $0.175 per share which is less than $0.50
per share.

 

4.4.
Adjustments in Exercise Price. Whenever the number of Class A ordinary shares purchasable upon the exercise of the Warrants is
adjusted, as provided in Sections 4.1 and 4.2 above, the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant
Price immediately prior to such adjustment by a fraction (x) the numerator of which shall be the number of Class A ordinary shares purchasable
upon the exercise of the Warrants immediately prior to such adjustment, and (y) the denominator of which shall be the number of Class
A ordinary shares so purchasable immediately thereafter.

 

    	5

     

    

 

4.5.
Replacement of Securities upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding Class
A ordinary shares (other than a change covered by Section 4.1, 4.2 or 4.3 hereof), or in the case of any merger or consolidation of the
Company with or into another corporation (other than a consolidation or merger in which the Company is the continuing corporation and
that does not result in any reclassification or reorganization of the outstanding Class A ordinary shares), or in the case of any sale
or conveyance to another corporation or entity of the assets or other property of the Company as an entirety or substantially as an entirety
in connection with which the Company is dissolved, the Warrant holders shall thereafter have the right to purchase and receive, upon
the basis and upon the terms and conditions specified in the Warrants and in lieu of the Class A ordinary shares of the Company immediately
theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares or other securities
or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following
any such sale or transfer, that the Warrant holder would have received if such Warrant holder had exercised his, her or its Warrant(s)
immediately prior to such event. If any reclassification also results in a change in the Class A ordinary shares covered by Section 4.1,
4.2 or 4.3, then such adjustment shall be made pursuant to Sections 4.1, 4.2, 4.3, 4.4 and this Section 4.5. The provisions of this Section
4.5 shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations, sales or other transfers. In no
event will the Warrant Price be reduced to less than the par value per share issuable upon exercise of the Warrant.

 

4.6.
Issuance in Connection with a Business Combination. If, in connection with a Business Combination, the Company (a) issues additional
Class A ordinary shares or equity-linked securities at an issue price or effective issue price of less than $9.20 per share (with such
issue price or effective issue price as determined by the Company’s Board of Directors, in good faith, and in the case of any such
issuance to the Sponsor, the initial stockholders or their affiliates, without taking into account any Company’s Class B ordinary
shares (the “Class B Shares”), issued prior to the Public Offering and held by the initial stockholders or their affiliates,
as applicable, prior to such issuance) (the “Newly Issued Price”), (b) the aggregate gross proceeds from such issuances
represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Business Combination on
the date of the consummation of such Business Combination (net of redemptions), and (c) the Market Value (as defined below) is below
$9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of
(i) the Market Value or (ii) Newly Issued Price, and the Redemption Trigger Price (as defined below) will be adjusted (to the nearest
cent) to be equal to 180% of the greater of (i) the Market Value or (ii) the Newly Issued Price. Solely for purposes of this Section
4.6, the “Market Value” shall mean the volume weighted average trading price of the Class A ordinary shares during
the twenty (20) trading day period starting on the trading day prior to the date of the consummation of the Business Combination.

 

4.7.
Notices of Changes in Warrant. Upon every adjustment of the Warrant Price or the number of shares issuable upon exercise of a
Warrant, the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting from
such adjustment and the increase or decrease, if any, in the number of shares purchasable at such price upon the exercise of a Warrant,
setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based. Upon the occurrence
of any event specified in Sections 4.1, 4.2, 4.3, 4.4, 4.5, or 4.6, then, in any such event, the Company shall give written notice to
each Warrant holder, at the last address set forth for such holder in the Warrant Register, of the record date or the effective date
of the event. Failure to give such notice, or any defect therein, shall not affect the legality or validity of such event.

 

4.8.
No Fractional Warrants or Shares. Notwithstanding any provision contained in this Agreement to the contrary, the Company shall
not issue fractional shares upon exercise of Warrants. If, by reason of any adjustment made pursuant to this Section 4, the holder of
any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share, the Company shall, upon
such exercise, round up to the nearest whole number of Class A ordinary shares to be issued to the Warrant holder.

 

4.9.
Form of Warrant. The form of Warrant need not be changed because of any adjustment pursuant to this Section 4, and Warrants issued
after such adjustment may state the same Warrant Price and the same number of shares as is stated in the Warrants initially issued pursuant
to this Agreement. However, the Company may at any time in its sole discretion make any change in the form of Warrant that the Company
may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter issued or countersigned, whether in exchange
or substitution for an outstanding Warrant or otherwise, may be in the form as so changed.

 

4.10.
Other Events. In case any event shall occur affecting the Company as to which none of the provisions of preceding subsections
of this Section 4 are strictly applicable, but which would require an adjustment to the terms of the Warrants in order to (i) avoid an
adverse impact on the Warrants and (ii) effectuate the intent and purpose of this Section 4, then, in each such case, the Company shall
appoint a firm of independent public accountants, investment banking or other appraisal firm of recognized national standing, which shall
give its opinion as to whether or not any adjustment to the rights represented by the Warrants is necessary to effectuate the intent
and purpose of this Section 4 and, if they determine that an adjustment is necessary, the terms of such adjustment. The Company shall
adjust the terms of the Warrants in a manner that is consistent with any adjustment recommended in such opinion.

 

    	6

     

    

 

4.11.
No Adjustment. For the avoidance of doubt, no adjustment shall be made to the terms of the Warrants solely as a result of an adjustment
to the conversion ratio of the Class B Shares into Class A ordinary shares or the conversion of the Class B Shares into Class A ordinary
shares, in each case, pursuant to the Company’s Articles of Formation, as amended from time to time.

 

5.
Transfer and Exchange of Warrants.

 

5.1.
Registration of Transfer. The Warrant Agent shall register the transfer, from time to time, of any outstanding Warrant upon the
Warrant Register, upon surrender of such Warrant for transfer, properly endorsed with signatures, in the case of certificated Warrants,
properly guaranteed and accompanied by appropriate instructions for transfer. Upon any such transfer, a new Warrant representing an equal
aggregate number of Warrants shall be issued and the old Warrant shall be cancelled by the Warrant Agent. In the case of certificated
Warrants, the Warrants so cancelled shall be delivered by the Warrant Agent to the Company from time to time upon request.

 

5.2.
Procedure for Surrender of Warrants. Warrants may be surrendered to the Warrant Agent, either in certificated form or in book
entry position, together with a written request for exchange or transfer, and thereupon the Warrant Agent shall issue in exchange therefor
one or more new Warrants, or book entry positions, as requested by the registered holder of the Warrants so surrendered, representing
an equal aggregate number of Warrants; provided, however, that in the event that a Warrant surrendered for transfer bears a restrictive
legend, the Warrant Agent shall not cancel such Warrant and issue new Warrants in exchange therefor until the Warrant Agent has received
an opinion of counsel for the Company stating that such transfer may be made and indicating whether the new Warrants must also bear a
restrictive legend.

 

5.3.
Fractional Warrants. The Warrant Agent shall not be required to effect any registration of transfer or exchange which will result
in the issuance of a warrant certificate or book-entry position for a fraction of a warrant, except as part of the Units.

 

5.4.
Service Charges. No service charge shall be made for any exchange or registration of transfer of Warrants.

 

5.5.
Warrant Execution and Countersignature. The Warrant Agent is hereby authorized to countersign and to deliver, in accordance with
the terms of this Agreement, the Warrants required to be issued pursuant to the provisions of this Section 5, and the Company, whenever
required by the Warrant Agent, will supply the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose.

 

5.6.
Private Warrants and Working Capital Warrants. The Warrant Agent shall not register any transfer of Private Warrants or Working
Capital Warrants until after the consummation by the Company of an initial Business Combination, except for transfers (i) among the initial
stockholders or to the Company’s or the initial stockholders’ members, officers, directors, consultants or their affiliates,
(ii) to a holder’s stockholders or members upon the holder’s liquidation, in each case if the holder is an entity, (iii)
by bona fide gift to a member of the holder’s immediate family or to a trust, the beneficiary of which is the holder or a member
of the holder’s immediate family, in each case for estate planning purposes, (iv) by virtue of the laws of descent and distribution
upon death, (v) pursuant to a qualified domestic relations order, (vi) to the Company for no value for cancellation in connection with
the consummation of a Business Combination, (vii) in connection with the consummation of a Business Combination at prices no greater
than the price at which the Warrants were originally purchased, (viii) in the event of the Company’s liquidation prior to its consummation
of an initial Business Combination or (ix) in the event that, subsequent to the consummation of an initial Business Combination, the
Company completes a liquidation, merger, capital stock exchange or other similar transaction which results in all of the Company’s
stockholders having the right to exchange their Class A ordinary shares for cash, securities or other property, in each case (except
for clauses (vi), (viii) or (ix) or with the Company’s prior written consent) on the condition that prior to such registration
for transfer, the Warrant Agent shall be presented with written documentation pursuant to which each transferee (each, a “Permitted
Transferee”) or the trustee or legal guardian for such Permitted Transferee agrees to be bound by the transfer restrictions
contained in this Agreement and any other applicable agreement the transferor is bound by.

 

    	7

     

    

 

5.7.
Transfers prior to Detachment. Prior to the Detachment Date, the Public Warrants may be transferred or exchanged only together
with the Unit in which such Warrant is included, and only for the purpose of effecting, or in conjunction with, a transfer or exchange
of such Unit. Furthermore, each transfer of a Unit on the register relating to such Units shall operate also to transfer the Warrants
included in such Unit. Notwithstanding the foregoing, the provisions of this Section 5.7 shall have no effect on any transfer of Warrants
on or after the Detachment Date.

 

6.
Redemption.

 

6.1.
Redemption. Not less than all of the outstanding Warrants may be redeemed, at the option of the Company, at any time during the
Exercise Period, at the office of the Warrant Agent, upon the notice referred to in Section 6.2, at the price of $0.01 per Warrant (“Redemption
Price”), provided that the last sales price of the Class A ordinary shares equals or exceeds $18.00 per share (subject to adjustment
in accordance with Section 4 hereof) (the “Redemption Trigger Price”), on each of twenty (20) trading days within
any thirty (30) trading day period commencing after the Warrants become exercisable and ending on the third trading day prior to the
date on which notice of redemption is given and provided that there is an effective registration statement covering the Class A ordinary
shares issuable upon exercise of the Warrants, and a current prospectus relating thereto, available throughout the 30-day redemption
or the Company has elected to require the exercise of the Warrants on a “cashless basis” pursuant to subsection 3.3.1(b);
provided, however, that if and when the Public Warrants become redeemable by the Company, the Company may not exercise such redemption
right if the issuance of Class A ordinary shares upon exercise of the Public Warrants is not exempt from registration or qualification
under applicable state blue sky laws or the Company is unable to effect such registration or qualification.

 

6.2.
Date Fixed for, and Notice of, Redemption. In the event the Company shall elect to redeem all of the Warrants that are subject
to redemption, the Company shall fix a date for the redemption (the “Redemption Date”). Notice of redemption shall
be mailed by first class mail, postage prepaid, by the Company not less than thirty (30) days prior to the Redemption Date to the registered
holders of the Warrants to be redeemed at their last addresses as they shall appear on the registration books. Any notice mailed in the
manner herein provided shall be conclusively presumed to have been duly given whether or not the registered holder received such notice.

 

6.3.
Exercise After Notice of Redemption. The Public Warrants may be exercised, for cash (or on a “cashless basis” in accordance
with Section 3 of this Agreement) at any time after notice of redemption shall have been given by the Company pursuant to Section 6.2
hereof and prior to the Redemption Date. In the event the Company determines to require all holders of Public Warrants to exercise their
Warrants on a “cashless basis” pursuant to Section 3.3.1(b), the notice of redemption will contain the information necessary
to calculate the number of Class A ordinary shares to be received upon exercise of the Warrants, including the “Fair Market Value”
in such case. On and after the Redemption Date, the record holder of the Warrants shall have no further rights except to receive, upon
surrender of the Warrants, the Redemption Price.

 

7.
Other Provisions Relating to Rights of Holders of Warrants.

 

7.1.
No Rights as Stockholder. A Warrant does not entitle the registered holder thereof to any of the rights of a stockholder of the
Company, including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive rights to vote
or to consent or to receive notice as stockholders in respect of the meetings of stockholders or the election of directors of the Company
or any other matter.

 

7.2.
Lost, Stolen, Mutilated, or Destroyed Warrants. If any Warrant is lost, stolen, mutilated, or destroyed, the Company and the Warrant
Agent may on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a mutilated
Warrant, include the surrender thereof), issue a new Warrant of like denomination, tenor, and date as the Warrant so lost, stolen, mutilated,
or destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company, whether or not the allegedly
lost, stolen, mutilated, or destroyed Warrant shall be at any time enforceable by anyone.

 

    	8

     

    

 

7.3.
Reservation of Class A ordinary shares. The Company shall at all times reserve and keep available a number of its authorized but
unissued Class A ordinary shares that will be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to
this Agreement.

 

7.4.
Registration of Class A ordinary shares. The Company agrees that as soon as practicable after the closing of its initial Business
Combination, it shall use its best efforts to file with the SEC a registration statement for the registration, under the Act, of the
Class A ordinary shares issuable upon exercise of the Warrants, and it shall use its best efforts to take such action as is necessary
to register or qualify for sale, in those states in which the Warrants were initially offered by the Company and in those states where
holders of Warrants then reside, the Class A ordinary shares issuable upon exercise of the Warrants, to the extent an exemption is not
available. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration
statement until the expiration of the Warrants in accordance with the provisions of this Agreement. If any such registration statement
has not been declared effective by the 60th Business Day following the closing of the Business Combination, holders of the Warrants shall
have the right, during the period beginning on the 61st Business Day after the closing of the Business Combination and ending upon such
registration statement being declared effective by the SEC, and during any other period when the Company shall fail to have maintained
an effective registration statement covering the Class A ordinary shares issuable upon exercise of the Warrants, to exercise such Warrants
on a “cashless basis” as determined in accordance with Section 3.3.1(c). The Company shall provide the Warrant Agent with
an opinion of counsel for the Company (which shall be an outside law firm with securities law experience) stating that (i) the exercise
of the Warrants on a cashless basis in accordance with this Section 7.4 is not required to be registered under the Act and (ii) the Class
A ordinary shares issued upon such exercise will be freely tradable under U.S. federal securities laws by anyone who is not an affiliate
(as such term is defined in Rule 144 under the Act) of the Company and, accordingly, will not be required to bear a restrictive legend.
For the avoidance of any doubt, unless and until all of the Warrants have been exercised on a cashless basis, the Company shall continue
to be obligated to comply with its registration obligations under the first three sentences of this Section 7.4.

 

8.
Concerning the Warrant Agent and Other Matters.

 

8.1.
Payment of Taxes. The Company will from time to time promptly pay all taxes and charges that may be imposed upon the Company or
the Warrant Agent in respect of the issuance or delivery of Class A ordinary shares upon the exercise of Warrants, but the Company shall
not be obligated to pay any transfer taxes in respect of the Warrants or such shares.

 

8.2.
Resignation, Consolidation, or Merger of Warrant Agent.

 

8.2.1.
Appointment of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and
be discharged from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the Company.
If the office of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing
a successor Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period of thirty
(30) days after it has been notified in writing of such resignation or incapacity by the Warrant Agent or by the holder of the Warrant
(who shall, with such notice, submit his Warrant for inspection by the Company), then the holder of any Warrant may apply to the Supreme
Court of the State of New York for the County of New York for the appointment of a successor Warrant Agent at the Company’s cost.
Any successor Warrant Agent, whether appointed by the Company or by such court, shall be a corporation organized and existing under the
laws of the State of New York, in good standing and having its principal office in the Borough of Manhattan, City and State of New York,
and authorized under such laws to exercise corporate trust powers and subject to supervision or examination by federal or state authority.
After appointment, any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities, duties, and obligations
of its predecessor Warrant Agent with like effect as if originally named as Warrant Agent hereunder, without any further act or deed;
but if for any reason it becomes necessary or appropriate, the predecessor Warrant Agent shall execute and deliver, at the expense of
the Company, an instrument transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant
Agent hereunder; and upon request of any successor Warrant Agent the Company shall make, execute, acknowledge, and deliver any and all
instruments in writing for more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority, powers,
rights, immunities, duties, and obligations.

 

    	9

     

    

 

8.2.2.
Notice of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof
to the predecessor Warrant Agent and the Transfer Agent for the Class A ordinary shares not later than the effective date of any such
appointment.

 

8.2.3.
Merger or Consolidation of Warrant Agent. Any corporation into which the Warrant Agent may be merged or with which it may be consolidated
or any corporation resulting from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor Warrant
Agent under this Agreement without any further act.

 

8.3.
Fees and Expenses of Warrant Agent.

 

8.3.1.
Remuneration. The Company agrees to pay the Warrant Agent reasonable remuneration for its services as such Warrant Agent hereunder
and will reimburse the Warrant Agent upon demand for all expenditures that the Warrant Agent may reasonably incur in the execution of
its duties hereunder.

 

8.3.2.
Further Assurances. The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed, acknowledged,
and delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Warrant Agent for the
carrying out or performing of the provisions of this Agreement.

 

8.4.
Liability of Warrant Agent.

 

8.4.1.
Reliance on Company Statement. Whenever in the performance of its duties under this Agreement, the Warrant Agent shall deem it
necessary or desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder,
such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved
and established by a statement signed by the Chief Executive Officer, Chief Financial Officer, Chief Operating Officer, President, Secretary
or Chairman of the Board of Directors of the Company and delivered to the Warrant Agent. The Warrant Agent may rely upon such statement
for any action taken or suffered in good faith by it pursuant to the provisions of this Agreement.

 

8.4.2.
Indemnity. The Warrant Agent shall be liable hereunder only for its own fraud, gross negligence, willful misconduct or bad faith.
The Company agrees to indemnify the Warrant Agent and save it harmless against any and all liabilities, including judgments, costs and
reasonable counsel fees, for anything done or omitted by the Warrant Agent in the execution of this Agreement except as a result of the
Warrant Agent’s fraud, gross negligence, willful misconduct, or bad faith.

 

8.4.3.
Exclusions. The Warrant Agent shall have no responsibility with respect to the validity of this Agreement or with respect to the
validity or execution of any Warrant (except its countersignature thereof); nor shall it be responsible for any breach by the Company
of any covenant or condition contained in this Agreement or in any Warrant; nor shall it be responsible to make any adjustments required
under the provisions of Section 4 hereof or responsible for the manner, method, or amount of any such adjustment or the ascertaining
of the existence of facts that would require any such adjustment; nor shall it by any act hereunder be deemed to make any representation
or warranty as to the authorization or reservation of any Class A ordinary shares to be issued pursuant to this Agreement or any Warrant
or as to whether any Class A ordinary shares will, when issued, be valid and fully paid and nonassessable.

 

8.5.
Acceptance of Agency. The Warrant Agent hereby accepts the agency established by this Agreement and agrees to perform the same
upon the terms and conditions herein set forth and among other things, shall account promptly to the Company with respect to Warrants
exercised and concurrently account for, and pay to the Company, all monies received by the Warrant Agent for the purchase of Class A
ordinary shares through the exercise of Warrants.

 

    	10

     

    

 

9.
Miscellaneous Provisions.

 

9.1.
Successors. All the covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall
bind and inure to the benefit of their respective successors and assigns.

 

9.2.
Notices. Any notice, statement or demand authorized by this Agreement to be given or made by the Warrant Agent or by the holder
of any Warrant to or on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified
mail or private courier service within five (5) days after deposit of such notice, postage prepaid, addressed (until another address
is filed in writing by the Company with the Warrant Agent), as follows:

 

Technology
& Telecommunication Acquisition Corporation

C3-2-23A,
Jalan 1/152, Taman OUG Parklane, Off Jalan Kelang Lama, 58200 Kuala Lumpur,

 Malaysia

Attn:
Chief Executive Officer

 

With
a copy to:

 

Loeb
& Loeb LLP

345
Park Avenue

New
York, New York 10154

Attn:
Mitchell S. Nussbaum, Esq.

 

Any
notice, statement or demand authorized by this Agreement to be given or made by the holder of any Warrant or by the Company to or on
the Warrant Agent shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private
courier service within five days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing
by the Warrant Agent with the Company), as follows:

 

Continental
Stock Transfer & Trust Company

1
State Street, 30th Floor

New
York, New York 10004

Attn:
Compliance Department

 

9.3.
Applicable Law and Exclusive Forum. The validity, interpretation, and performance of this Agreement and of the Warrants shall
be governed in all respects by the laws of the State of New York, without giving effect to conflicts of law principles that would result
in the application of the substantive laws of another jurisdiction. Subject to applicable law, the Company hereby agrees that any action,
proceeding or claim against it arising out of or relating in any way to this Agreement, including under the Act, shall be brought and
enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and irrevocably
submits to such jurisdiction, which jurisdiction shall be exclusive forum for any such action, proceeding or claim. The Company hereby
waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Notwithstanding the foregoing,
the provisions of this paragraph will not apply to suits brought to enforce any liability or duty created by the Exchange Act or any
other claim for which the federal district courts of the United States of America are the sole and exclusive forum.

 

Any
person or entity purchasing or otherwise acquiring any interest in the Warrants shall be deemed to have notice of and to have consented
to the forum provisions in this Section 9.3. If any action, the subject matter of which is within the scope the forum provisions above,
is filed in a court other than a court located within the State of New York or the United States District Court for the Southern District
of New York (a “foreign action”) in the name of any warrant holder, such warrant holder shall be deemed to have consented
to: (x) the personal jurisdiction of the state and federal courts located within the State of New York or the United States District
Court for the Southern District of New York in connection with any action brought in any such court to enforce the forum provisions (an
“enforcement action”), and (y) having service of process made upon such warrant holder in any such enforcement action by
service upon such warrant holder’s counsel in the foreign action as agent for such warrant holder.

 

9.4.
Persons Having Rights under this Agreement. Nothing in this Agreement expressed and nothing that may be implied from any of the
provisions hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation other than the parties hereto
and the registered holders of the Warrants any right, remedy, or claim under or by reason of this Agreement or of any covenant, condition,
stipulation, promise, or agreement hereof. All covenants, conditions, stipulations, promises, and agreements contained in this Agreement
shall be for the sole and exclusive benefit of the parties hereto and their successors and assigns and of the registered holders of the
Warrants.

 

    	11

     

    

 

9.5.
Examination of the Warrant Agreement. A copy of this Agreement shall be available at all reasonable times at the office of the
Warrant Agent in the Borough of Manhattan, City and State of New York, for inspection by the registered holder of any Warrant. The Warrant
Agent may require any such holder to submit his Warrant for inspection by it.

 

9.6.
Counterparts. This Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts
shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

 

9.7.
Effect of Headings. The section headings herein are for convenience only and are not part of this Agreement and shall not affect
the interpretation thereof.

 

9.8.
Amendments. This Agreement may be amended by the parties hereto without the consent of any registered holder for the purpose of
(i) curing any ambiguity or to correct any mistake, including to conform the provisions hereof to the description of the terms of the
Warrants and this Agreement set forth in the Prospectus, or curing, correcting or supplementing any defective provision contained herein,
or (ii) adding or changing any other provisions with respect to matters or questions arising under this Agreement as the parties may
deem necessary or desirable and that the parties deem shall not adversely affect the interest of the registered holders. All other modifications
or amendments, including any amendment to increase the Warrant Price or shorten the Exercise Period, shall require the written consent
or vote of the registered holders of at least 50% of the then outstanding Public Warrants. Notwithstanding the foregoing, the Company
may lower the Warrant Price or extend the duration of the Exercise Period pursuant to Sections 3.1 and 3.2, respectively, without the
consent of the registered holders.

 

9.9.
Trust Account Waiver. The Warrant Agent acknowledges and agrees that it shall not make any claims or proceed against the trust
account established by the Company in connection with the Public Offering (as more fully described in the Registration Statement) (“Trust
Account”), including by way of set-off, and shall not be entitled to any funds in the Trust Account under any circumstance.
In the event that the Warrant Agent has a claim against the Company under this Agreement, the Warrant Agent will pursue such claim solely
against the Company and not against the property held in the Trust Account.

 

9.10.
Severability. This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof
shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any
such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision
as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

 

[Signature
Page Follows]

 

    	12

     

    

 

IN
WITNESS WHEREOF, this Agreement has been duly executed by the parties hereto as of the day and year first above written.

 

	 	TECHNOLOGY
    & TELECOMMUNICATION ACQUISITION CORPORATION
	 	 	 
	 	By:	                                             
	 	Name:	Ng
    Tek Che
	 	Title:	Chief
Executive Officer
	 	 	 
	 	CONTINENTAL
    STOCK TRANSFER & TRUST COMPANY, as Warrant Agent
	 	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 

 

[Signature
Page to Warrant Agreement]

 

Exhibit
A – Form of Warrant Certificate

 

Exhibit
B – Legend

 

    	13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}]]